161 related articles for article (PubMed ID: 38148738)
1. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
Malkiewicz JJ; Siuda J
Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.
Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study.
Nojszewska M; Potulska-Chromik A; Jamrozik Z; Janik P; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2019; 53(1):26-33. PubMed ID: 30620042
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes.
Holmberg B; Kallio M; Johnels B; Elam M
Mov Disord; 2001 Mar; 16(2):217-25. PubMed ID: 11295773
[TBL] [Abstract][Full Text] [Related]
5. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.
Schmidt C; Berg D; ; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Ziemssen T
Mov Disord; 2009 Oct; 24(14):2136-42. PubMed ID: 19768815
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Reimann M; Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schoels L; Reichmann H; Berg D; Ziemssen T
J Neural Transm (Vienna); 2010 Jan; 117(1):69-76. PubMed ID: 19763772
[TBL] [Abstract][Full Text] [Related]
7. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
8. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
10. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Kim KJ; Jeong SJ; Kim JM
Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
[TBL] [Abstract][Full Text] [Related]
11. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
12. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
13. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
14. Valsalva manoeuvre in patients with different Parkinsonian disorders.
Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Berg D; Ziemssen T
J Neural Transm (Vienna); 2009 Jul; 116(7):875-80. PubMed ID: 19499177
[TBL] [Abstract][Full Text] [Related]
15. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
[TBL] [Abstract][Full Text] [Related]
16. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
17. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
[TBL] [Abstract][Full Text] [Related]
18. Supine hypertension in Parkinson's disease and multiple system atrophy.
Fanciulli A; Göbel G; Ndayisaba JP; Granata R; Duerr S; Strano S; Colosimo C; Poewe W; Pontieri FE; Wenning GK
Clin Auton Res; 2016 Apr; 26(2):97-105. PubMed ID: 26801189
[TBL] [Abstract][Full Text] [Related]
19. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels in Parkinson's disease and related disorders.
Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
